Brief: Lineage Cell Provides Update On OPC1 Cell Therapy Program For Spinal Cord Injury
25/06/2020 13:33
June 25 (Reuters) - Lineage Cell Therapeutics Inc LCTX.A :
* LINEAGE CELL THERAPEUTICS PROVIDES UPDATE ON OPC1 CELL
THERAPY
PROGRAM FOR SPINAL CORD INJURY
* LINEAGE CELL THERAPEUTICS - INTENDS TO MEET WITH U.S. FOOD
AND
DRUG ADMINISTRATION TO DISCUSS FURTHER DEVELOPMENT OF OPC1
PROGRAM BY END OF 2020
Source text for Eikon: ID:nBwc3n0QQa
Further company coverage: LCTX.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million